Jefferson Capital adds two directors to board
Get Alerts JCAP Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 6.7%
EPS Growth %: -23.5%
Join SI Premium – FREE
Jefferson Capital Inc. (NASDAQ: JCAP) appointed Susan Atkins and James Pierce as independent directors to its board, effective March 18, 2026. The company also announced that Christopher Giles stepped down from the board after serving since 2018.
Atkins brings more than 40 years of experience in corporate finance, risk management, strategy and governance. She previously served as Global Head of Wholesale Restructuring at JPMorgan and currently serves as an independent director for several companies. She also serves on the Creditor Advisory Committee of the FTX Post-Bankruptcy Trust.
Pierce currently serves as Chief Operating Officer at Minnesota Diversified Industries and previously held the position of Chief Information Officer at SALO Korn Ferry. He spent over 30 years at Cargill in various leadership roles in information technology and commercial business development. Pierce also serves as an independent board director at MinnWest Bank.
"Both Sue and James are proven leaders with extensive operational and commercial capabilities," said David Burton, Chairman and Chief Executive Officer. "Sue's extensive experience working on complex restructurings and in risk management, and James' technology leadership and broad expertise in cybersecurity oversight and enterprise risk management make them ideal additions to our Board."
Burton thanked Giles for his contributions over seven years, noting his role during the company's transition to becoming publicly traded.
Jefferson Capital purchases and manages charged-off, insolvency and active consumer accounts. The company operates in the United States, Canada, the United Kingdom and Latin America, serving clients including banks, fintech platforms, telecommunications providers and credit card issuers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Select Medical stockholders approve buyout by insider-led consortium
- Larimar Therapeutics to host investor event on June 29
- TEN Holdings prices $7.5 million common stock offering at $1 per share
Create E-mail Alert Related Categories
Board Changes, Corporate NewsRelated Entities
JPMorgan, Bankruptcy, Maynard Um, AdCom, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share